|
2024 Book Chapter Development and expansion of patient-derived xenografts for endometrial cancerSengal, Asmerom T. and Pollock, Pamela M. (2024). Development and expansion of patient-derived xenografts for endometrial cancer. Patient-derived xenografts: methods and protocols. (pp. 101-115) edited by Mohamed I. Saad. New York, NY USA: Humana Press. doi: 10.1007/978-1-0716-3858-3_9 |
|
2023 Journal Article Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibitionSengal, Asmerom T., Bonazzi, Vanessa, Smith, Deborah, Moiola, Cristian P., Lourie, Rohan, Rogers, Rebecca, Colas, Eva, Gil-Moreno, Antonio, Frentzas, Sophia, Chetty, Naven, Perrin, Lewis and Pollock, Pamela M. (2023). Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition. npj Precision Oncology, 7 (1) 127, 127. doi: 10.1038/s41698-023-00478-6 |
|
2022 Journal Article Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinomaSengal, Asmerom T., Smith, Deborah, Snell, Cameron E., Leung, Samuel, Talhouk, Aline, Williams, Elizabeth D., McAlpine, Jessica N. and Pollock, Pamela M. (2022). Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma. Journal of Pathology: Clinical Research, 8 (6), 521-537. doi: 10.1002/cjp2.286 |
|
2022 Journal Article Patient-derived xenograft models capture genomic heterogeneity in endometrial cancerBonazzi, Vanessa F., Kondrashova, Olga, Smith, Deborah, Nones, Katia, Sengal, Asmerom T., Ju, Robert, Packer, Leisl M., Koufariotis, Lambros T., Kazakoff, Stephen H., Davidson, Aimee L., Ramarao-Milne, Priya, Lakis, Vanessa, Newell, Felicity, Rogers, Rebecca, Davies, Claire, Nicklin, James, Garrett, Andrea, Chetty, Naven, Perrin, Lewis, Pearson, John V., Patch, Ann-Marie, Waddell, Nicola and Pollock, Pamela M. (2022). Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer. Genome Medicine, 14 (1) 3, 1-19. doi: 10.1186/s13073-021-00990-z |
|
2021 Conference Publication Targeting FGFR2c isoform, a novel therapeutic target with FGFR inhibitor in endometrial cancerSengal, Asmerom T., Bonazzi, Vanessa, Kondrashova, Olga, Perrin, Lewis, Chetty, Naven, Smith, Deborah, Gil-Moreno, Antonio, Colas, Eva and Pollock, Pamela M. (2021). Targeting FGFR2c isoform, a novel therapeutic target with FGFR inhibitor in endometrial cancer. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-21-LBA020 |
|
2021 Journal Article Fibroblast growth factor receptor 2 isoforms detected via novel RNA ISH as predictive biomarkers for progestin therapy in atypical hyperplasia and low-grade endometrial cancerSengal, Asmerom T., Smith, Deborah, Rogers, Rebecca, Snell, Cameron E., Williams, Elizabeth D. and Pollock, Pamela M. (2021). Fibroblast growth factor receptor 2 isoforms detected via novel RNA ISH as predictive biomarkers for progestin therapy in atypical hyperplasia and low-grade endometrial cancer. Cancers, 13 (7) 1703, 1-17. doi: 10.3390/cancers13071703 |
|
2021 Conference Publication FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancerSengal, Asmerom, Smith, Deborah, Rogers, Rebecca, Snell, Cameron, Williams, Elizabeth and Pollock, Pamela (2021). FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer. AACR Virtual Special Conference: Endometrial Cancer: New Biology Driving Research and Treatment, Virtual, 9-10 November 2020. Philadelphia, PA USA: American Association for Cancer Research. doi: 10.1158/1557-3265.endomet20-po033 |
|
2021 Conference Publication Genomic characterization of endometrial cancer patient-derived xenografts reveals intratumor heterogeneityKondrashova, Olga, Bonazzi, Vanessa F., Smith, Deborah, Nones, Katia, Sengal, Asmerom, Ju, Robert, Packer, Leisl M., Koufariotis, Lambros T., Kazakoff, Stephen H., Davidson, Aimee L., Ramarao-Milne, Priya, Lakis, Vanessa, Newell, Felicity, Rogers, Rebecca, Davies, Claire, Chetty, Naven, Perrin, Lewis, Pearson, John, Patch, Ann-Marie, Garrett, Andrea, Waddell, Nicola, Pollock, Pamela and Nicklin, James (2021). Genomic characterization of endometrial cancer patient-derived xenografts reveals intratumor heterogeneity. AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, Electr Network, Nov 09-10, 2020. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
|
2021 Conference Publication FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancerSengal, Asmerom, Smith, Deborah, Rogers, Rebecca, Snell, Cameron, Williams, Elizabeth and Pollock, Pamela (2021). FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer. AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, Electr Network, Nov 09-10, 2020. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
|
2020 Journal Article FGFR2c mesenchymal isoform expression is associated with poor prognosis and further refines risk stratification within endometrial cancer molecular subtypesSengal, Asmerom T., Patch, Ann-Marie, Snell, Cameron E., Smith, Deborah S., Leung, Samuel, Talhouk, Aline, Williams, Elizabeth D., McAlpine, Jessica N. and Pollock, Pamela M. (2020). FGFR2c mesenchymal isoform expression is associated with poor prognosis and further refines risk stratification within endometrial cancer molecular subtypes. Clinical Cancer Research, 26 (17), 4569-4580. doi: 10.1158/1078-0432.ccr-19-4088 |
|
2017 Journal Article Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case seriesSengal, Asmerom Tesfamariam, Haj-Mukhtar, Nada Suliman, Elhaj, Ahmed Mohammed, Bedri, Shahinaz, Kantelhardt, Eva Johanna and Mohamedani, Ahmed A. (2017). Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series. BMC Cancer, 17 (1) 804, 1-9. doi: 10.1186/s12885-017-3805-4 |
|
2017 Journal Article Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort StudySengal, Asmerom Tesfamariam, Mukhtar, Nada Suliman Haj, Vetter, Martina, Elhaj, Ahmed Mohammed, Bedri, Shahinaz, Hauptmann, Steffen, Thomssen, Christoph, Mohamedani, Ahmed Abdalla, Wickenhauser, Claudia and Kantelhardt, Eva Johanna (2017). Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study. Journal of Global Oncology, 4 (4), 1-12. doi: 10.1200/JGO.2017.010082 |
|
2016 Journal Article The Role of PCR in Diagnosis of a Rare Appendicular Tuberculosis and Mini Literature ReviewSengal, Asmerom Tesfamariam, Mohamedani, Ahmed Abdalla, Hussein, Hanan Hasaan and Kamal, Alaa (2016). The Role of PCR in Diagnosis of a Rare Appendicular Tuberculosis and Mini Literature Review. Case Reports in Gastrointestinal Medicine, 2016 8356708. doi: 10.1155/2016/8356708 |
|
2013 Journal Article Breast cancer clinicopathological presentation, gravity and challenges in Eritrea, East Africa: management practice in a resource-poor settingTesfamariam, A., Gebremichael, A. and Mufunda, J. (2013). Breast cancer clinicopathological presentation, gravity and challenges in Eritrea, East Africa: management practice in a resource-poor setting. South African Medical Journal, 103 (8), 526-528. doi: 10.7196/SAMJ.6829 |
|
2013 Journal Article Molecular biology of breast cancer in the Horn of Africa: case series—a pilot study of breast cancer from EritreaTesfamariam, Asmerom and Roy, Indrojit (2013). Molecular biology of breast cancer in the Horn of Africa: case series—a pilot study of breast cancer from Eritrea. ISRN Pathology, 2013, 1-7. doi: 10.1155/2013/787495 |
